Cargando…
The Ethics of Switch/Simplify in Antiretroviral Trials: Non-Inferior or Just Inferior?
Using the SWITCHMRK and MONET trials as examples, Andrew Carr and colleagues question the ethics and motives of switch or simplification trials of anti-retroviral therapy.
Autores principales: | Carr, Andrew, Hoy, Jennifer, Pozniak, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398965/ https://www.ncbi.nlm.nih.gov/pubmed/22815652 http://dx.doi.org/10.1371/journal.pmed.1001240 |
Ejemplares similares
-
Necrosis of the Right Inferior Maxillary Bone
por: Richardson, J.
Publicado: (1864) -
Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
por: Savulescu, Julian, et al.
Publicado: (2016) -
The Ethics and Politics of Academic Knowledge Production: Thoughts on the Future of Business Ethics
por: Burrell, Gibson, et al.
Publicado: (2022) -
Non-inferiority trials
por: Ranganathan, Priya, et al.
Publicado: (2022) -
Predicting Harms and Benefits in Translational Trials: Ethics,
Evidence, and Uncertainty
por: Kimmelman, Jonathan, et al.
Publicado: (2011)